898 related articles for article (PubMed ID: 16496232)
21. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
Taghavi SA; Eshraghian A; Niknam R; Sivandzadeh GR; Bagheri Lankarani K
Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
[TBL] [Abstract][Full Text] [Related]
22. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
[TBL] [Abstract][Full Text] [Related]
23. High lifetime risk of cancer in primary sclerosing cholangitis.
Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
[TBL] [Abstract][Full Text] [Related]
24. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
25. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.
Albiin N; Smith IC; Arnelo U; Lindberg B; Bergquist A; Dolenko B; Bryksina N; Bezabeh T
Acta Radiol; 2008 Oct; 49(8):855-62. PubMed ID: 18608012
[TBL] [Abstract][Full Text] [Related]
26. Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience.
Kaya M; de Groen PC; Angulo P; Nagorney DM; Gunderson LL; Gores GJ; Haddock MG; Lindor KD
Am J Gastroenterol; 2001 Apr; 96(4):1164-9. PubMed ID: 11316165
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
[TBL] [Abstract][Full Text] [Related]
28. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
29. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
[TBL] [Abstract][Full Text] [Related]
30. Recall processes for biliary cytology in primary sclerosing cholangitis.
Eaton JE; Gossard AA; Talwalkar JA
Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
Baskin-Bey ES; Moreno Luna LE; Gores GJ
J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574
[No Abstract] [Full Text] [Related]
32. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
33. Transplantation for hilar cholangiocarcinoma.
Heimbach JK; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB; Gores GJ
Liver Transpl; 2004 Oct; 10(10 Suppl 2):S65-8. PubMed ID: 15382214
[TBL] [Abstract][Full Text] [Related]
34. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis.
Saca D; Flamm SL
Clin Liver Dis; 2024 Feb; 28(1):183-192. PubMed ID: 37945159
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
36. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
Quinn KP; Tabibian JH; Lindor KD
Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
[TBL] [Abstract][Full Text] [Related]
38. Primary sclerosing cholangitis.
Rodriguez HJ; Bass NM
Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
[TBL] [Abstract][Full Text] [Related]
39. Advanced cholangiocarcinoma in a patient with stage I primary sclerosing cholangitis.
Ueda M; Nakamura T; Tohyama T; Kushihata F; Honda Y; Kobayashi N
J Hepatobiliary Pancreat Surg; 2003; 10(3):245-9. PubMed ID: 14605983
[TBL] [Abstract][Full Text] [Related]
40. Sclerosing cholangitis.
MacFaul GR; Chapman RW
Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
